Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors

Endocrine-resistant, hormone receptor-positive, and HER2-negative (HR+/HER2-) metastatic breast cancer (mBC) is largely governed by acquired mutations in the estrogen receptor, which promote ligand-independent activation, and by truncal alterations in the PI3K signaling pathway, with a broader range...

ver descrição completa

Detalhes bibliográficos
Principais autores: Fuentes-Antrás, Jesús, Martínez-Rodríguez, Ana, Guevara-Hoyer, Kissy, López-Cade, Igor, Lorca, Víctor, Pascual, Alejandro, de Luna, Alicia, Ramírez-Ruda, Carmen, Swindell, Jennifer, Flores, Paloma, Lluch, Ana, Cescon, David W., Pérez-Segura, Pedro, Ocaña, Alberto, Jones, Frederick, Moreno, Fernando, García-Barberán, Vanesa, García-Sáenz, José Ángel
Formato: Online Atigo Texto
Idioma:English
Publicado em: MDPI 2023
Assuntos:
Article
Acesso em linha:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379453/
https://www.ncbi.nlm.nih.gov/pubmed/37511178
http://dx.doi.org/10.3390/ijms241411419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379453/
https://www.ncbi.nlm.nih.gov/pubmed/37511178
http://dx.doi.org/10.3390/ijms241411419

Registros relacionados